Company: RPTX
Filing Date: 2025-11-17
Form Type: DEFA14A
Source: 0001193125-25-284040
Chunk: 31

Company: Repare Therapeutics Inc.
Filing Date: 2025-11-17
Form: DEFA14A
Chunk 31
---
 or to perform any search of any public registry office or system (and, without limiting the foregoing, each such individual will be deemed to have “knowledge” of a particular fact or other matter if (a) that individual is actually aware of that fact or matter; or (b) that fact or matter comes to the attention of that individual under circumstances in which a reasonable person would take cognizance of it).

| 1.4 | Currency |

Unless otherwise indicated, all dollar amounts referred to in this Agreement are expressed in lawful money of the United States.

| 1.5 | Accounting Principles |

Any reference in this Agreement to generally accepted accounting principles or “GAAP” refers to accounting principles which have been established in accordance with GAAP, applied on a consistent basis, and which are applicable in the circumstances as of the date in question. Accounting principles shall be applied on a “consistent basis” when the accounting principles applied in a current period are comparable in all material respects to those accounting principles applied in a preceding period.

| 1.6 | Disclosure in Writing |

| (a) | Reference to disclosure in writing herein shall, in the case of the Company, be limited to the disclosures made                                                                                                                                           
 by the Company in this Agreement (including the Schedules hereto) and the Disclosure Letter. The Parties acknowledge and agree that notwithstanding that information may be provided in this Agreement (including the Schedules hereto) or the Disclosure 
 Letter under one particular heading of this Agreement that information will be considered to qualify any other relevant representation in or provide information in respect of any other relevant provision of this Agreement to the extent it is         
 reasonably apparent that such information is applicable to such other provision of this Agreement and such representation is so qualified by a reference to disclosure in writing.                                                                        |

| (b) | The Disclosure Letter itself and all information contained in it is confidential information and may not be                                                                                                                               
 disclosed unless (i) it is required to be disclosed pursuant to Law unless such Law permits the Parties to refrain from disclosing the information for confidentiality or other purposes or (ii) a Party needs to disclose it in order to 
 enforce or exercise its rights under this Agreement.                                                                                                                                                                                      |

| 1.7 | Schedules |

The following Schedules are annexed to and form an integral part of this Agreement: Schedule A – Plan of Arrangement Schedule B – Arrangement Resolution Schedule C – Representations and Warranties of the Purchaser and Parent - 15 -

Schedule D – Representations and Warranties of X